Global Opioids Drug Supply, Demand and Key Producers, 2026-2032
The global Opioids Drug market size is expected to reach $ 8680 million by 2032, rising at a market growth of -1.8% CAGR during the forecast period (2026-2032).
Opioid drugs are prescription medicines that act on mu, kappa, delta, and other opioid receptors in the central and peripheral nervous systems to produce analgesia, sedation, cough suppression, or relief from opioid withdrawal symptoms. Based on their origin and chemical structure, they can be classified as natural opiates, semi-synthetic opioids derived from opium alkaloids, and fully synthetic opioids. By clinical application, the category includes medicines for acute and chronic pain management, perioperative and anesthesia support, palliative care, and certain partial agonist or antagonist-containing therapies used to treat opioid use disorder. Major dosage forms include immediate- and extended-release oral formulations, injectable products, transdermal patches, transmucosal formulations, and long-acting injections. Opioids provide clinically important and sometimes difficult-to-replace therapeutic benefits, but they may also cause tolerance, physical dependence, addiction, respiratory depression, and overdose. Their development, manufacturing, distribution, prescribing, administration, and disposal are therefore subject to extensive regulatory controls.In 2025, global Opioid drugs production reached approximately 9500 million units.The average gross profit margin of this product is 75%.
Growth in surgical procedures, cancer and severe-trauma treatment, population aging, and the development of palliative care continue to support legitimate hospital demand for potent opioid analgesics and anesthesia-related products. In severe acute pain, cancer pain, end-of-life care, and selected complex perioperative settings, opioids retain advantages such as rapid onset, strong analgesic efficacy, and extensive clinical experience. Market development is increasingly centered on improving treatment precision and safety rather than expanding overall exposure. Relevant innovation areas include readily titratable short-acting products, extended-release formulations designed to reduce misuse, prefilled or ready-to-use injectables, and more reliable hospital supply systems. At the same time, opioid use disorder is increasingly managed as a chronic medical condition, creating a distinct and specialized market for long-acting buprenorphine, combination therapies, and treatment options capable of improving adherence and continuity of care.
The central challenge for the opioid industry is balancing clinical benefit with substantial public-health risk. Prolonged or inappropriate use may lead to tolerance, physical dependence, addiction, respiratory depression, misuse, and overdose, prompting regulators to strengthen prescribing information, risk education, product tracking, unused-drug disposal, and patient monitoring. Tighter prescribing practices and the development of non-opioid analgesics are reducing opioid use in some routine pain indications. Manufacturers also face controlled-substance quotas, approved sourcing requirements, strict inventory controls, secure transportation, diversion-prevention obligations, and extensive recordkeeping. Historical litigation, reputational exposure, and potential settlement liabilities may create lasting financial and brand-related consequences. Although illicit fentanyl is distinct from properly manufactured and prescribed pharmaceutical opioids, the broader social crisis can negatively affect public perceptions of the entire drug class and increase uncertainty in the regulatory and commercial environment.
Hospitals, surgical centers, oncology institutions, pain clinics, and palliative-care providers will remain the principal end users of pharmaceutical opioids. Procurement decisions, however, are shifting beyond efficacy and price toward supply reliability, convenient dosage forms, dosing flexibility, and risk-management capabilities. Acute-pain treatment increasingly emphasizes the shortest necessary treatment duration and multimodal analgesia, with opioids used alongside non-opioid analgesics, regional anesthesia, and other supportive therapies. Use in chronic non-cancer pain is expected to remain cautious, while cancer pain, critical care, severe trauma, and end-of-life treatment retain stronger clinical necessity. Treatment for opioid use disorder is progressing toward longer-acting, outpatient-based, and continuous-care models, supporting demand for extended-release injectables, buprenorphine-based medicines, and the complementary supply of naloxone. Future product competition will increasingly focus on differentiated delivery systems, safer administration, misuse reduction, dependable supply, and demonstrable real-world clinical value.
This report studies the global Opioids Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioids Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioids Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioids Drug total production and demand, 2021-2032, (M Units)
Global Opioids Drug total production value, 2021-2032, (USD Million)
Global Opioids Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Opioids Drug consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Opioids Drug domestic production, consumption, key domestic manufacturers and share
Global Opioids Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Opioids Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Opioids Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Purdue Pharma, Johnson & Johnson Janssen, Teva Pharmaceutical, Hikma Pharmaceuticals, Pfizer, Indivior, Mundipharma, Yichang Humanwell, Northeast Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioids Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioids Drug Market, By Region:
1. How big is the global Opioids Drug market?
2. What is the demand of the global Opioids Drug market?
3. What is the year over year growth of the global Opioids Drug market?
4. What is the production and production value of the global Opioids Drug market?
5. Who are the key producers in the global Opioids Drug market?
6. What are the growth factors driving the market demand?
Opioid drugs are prescription medicines that act on mu, kappa, delta, and other opioid receptors in the central and peripheral nervous systems to produce analgesia, sedation, cough suppression, or relief from opioid withdrawal symptoms. Based on their origin and chemical structure, they can be classified as natural opiates, semi-synthetic opioids derived from opium alkaloids, and fully synthetic opioids. By clinical application, the category includes medicines for acute and chronic pain management, perioperative and anesthesia support, palliative care, and certain partial agonist or antagonist-containing therapies used to treat opioid use disorder. Major dosage forms include immediate- and extended-release oral formulations, injectable products, transdermal patches, transmucosal formulations, and long-acting injections. Opioids provide clinically important and sometimes difficult-to-replace therapeutic benefits, but they may also cause tolerance, physical dependence, addiction, respiratory depression, and overdose. Their development, manufacturing, distribution, prescribing, administration, and disposal are therefore subject to extensive regulatory controls.In 2025, global Opioid drugs production reached approximately 9500 million units.The average gross profit margin of this product is 75%.
Growth in surgical procedures, cancer and severe-trauma treatment, population aging, and the development of palliative care continue to support legitimate hospital demand for potent opioid analgesics and anesthesia-related products. In severe acute pain, cancer pain, end-of-life care, and selected complex perioperative settings, opioids retain advantages such as rapid onset, strong analgesic efficacy, and extensive clinical experience. Market development is increasingly centered on improving treatment precision and safety rather than expanding overall exposure. Relevant innovation areas include readily titratable short-acting products, extended-release formulations designed to reduce misuse, prefilled or ready-to-use injectables, and more reliable hospital supply systems. At the same time, opioid use disorder is increasingly managed as a chronic medical condition, creating a distinct and specialized market for long-acting buprenorphine, combination therapies, and treatment options capable of improving adherence and continuity of care.
The central challenge for the opioid industry is balancing clinical benefit with substantial public-health risk. Prolonged or inappropriate use may lead to tolerance, physical dependence, addiction, respiratory depression, misuse, and overdose, prompting regulators to strengthen prescribing information, risk education, product tracking, unused-drug disposal, and patient monitoring. Tighter prescribing practices and the development of non-opioid analgesics are reducing opioid use in some routine pain indications. Manufacturers also face controlled-substance quotas, approved sourcing requirements, strict inventory controls, secure transportation, diversion-prevention obligations, and extensive recordkeeping. Historical litigation, reputational exposure, and potential settlement liabilities may create lasting financial and brand-related consequences. Although illicit fentanyl is distinct from properly manufactured and prescribed pharmaceutical opioids, the broader social crisis can negatively affect public perceptions of the entire drug class and increase uncertainty in the regulatory and commercial environment.
Hospitals, surgical centers, oncology institutions, pain clinics, and palliative-care providers will remain the principal end users of pharmaceutical opioids. Procurement decisions, however, are shifting beyond efficacy and price toward supply reliability, convenient dosage forms, dosing flexibility, and risk-management capabilities. Acute-pain treatment increasingly emphasizes the shortest necessary treatment duration and multimodal analgesia, with opioids used alongside non-opioid analgesics, regional anesthesia, and other supportive therapies. Use in chronic non-cancer pain is expected to remain cautious, while cancer pain, critical care, severe trauma, and end-of-life treatment retain stronger clinical necessity. Treatment for opioid use disorder is progressing toward longer-acting, outpatient-based, and continuous-care models, supporting demand for extended-release injectables, buprenorphine-based medicines, and the complementary supply of naloxone. Future product competition will increasingly focus on differentiated delivery systems, safer administration, misuse reduction, dependable supply, and demonstrable real-world clinical value.
This report studies the global Opioids Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioids Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioids Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioids Drug total production and demand, 2021-2032, (M Units)
Global Opioids Drug total production value, 2021-2032, (USD Million)
Global Opioids Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Opioids Drug consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Opioids Drug domestic production, consumption, key domestic manufacturers and share
Global Opioids Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Opioids Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Opioids Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Purdue Pharma, Johnson & Johnson Janssen, Teva Pharmaceutical, Hikma Pharmaceuticals, Pfizer, Indivior, Mundipharma, Yichang Humanwell, Northeast Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioids Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioids Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Cancer Pain
- Postoperative Pain
- Chronic Severe Pain
- Other
- Immediate-release Tablet
- Controlled-release Tablet
- Injection
- Transdermal Patch
- Other
- Pain Relief
- Anesthesia
- Others
- Mallinckrodt Pharmaceuticals
- Purdue Pharma
- Johnson & Johnson Janssen
- Teva Pharmaceutical
- Hikma Pharmaceuticals
- Pfizer
- Indivior
- Mundipharma
- Yichang Humanwell
- Northeast Pharmaceutical
- Viatris
- Depomed
- Endo Pharmaceuticals
1. How big is the global Opioids Drug market?
2. What is the demand of the global Opioids Drug market?
3. What is the year over year growth of the global Opioids Drug market?
4. What is the production and production value of the global Opioids Drug market?
5. Who are the key producers in the global Opioids Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Opioids Drug Introduction
1.2 World Opioids Drug Supply & Forecast
1.2.1 World Opioids Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Opioids Drug Production (2021-2032)
1.2.3 World Opioids Drug Pricing Trends (2021-2032)
1.3 World Opioids Drug Production by Region (Based on Production Site)
1.3.1 World Opioids Drug Production Value by Region (2021-2032)
1.3.2 World Opioids Drug Production by Region (2021-2032)
1.3.3 World Opioids Drug Average Price by Region (2021-2032)
1.3.4 North America Opioids Drug Production (2021-2032)
1.3.5 Europe Opioids Drug Production (2021-2032)
1.3.6 Israel Opioids Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Opioids Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Opioids Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Opioids Drug Demand (2021-2032)
2.2 World Opioids Drug Consumption by Region
2.2.1 World Opioids Drug Consumption by Region (2021-2026)
2.2.2 World Opioids Drug Consumption Forecast by Region (2027-2032)
2.3 United States Opioids Drug Consumption (2021-2032)
2.4 China Opioids Drug Consumption (2021-2032)
2.5 Europe Opioids Drug Consumption (2021-2032)
2.6 Japan Opioids Drug Consumption (2021-2032)
2.7 South Korea Opioids Drug Consumption (2021-2032)
2.8 ASEAN Opioids Drug Consumption (2021-2032)
2.9 India Opioids Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Opioids Drug Production Value by Manufacturer (2021-2026)
3.2 World Opioids Drug Production by Manufacturer (2021-2026)
3.3 World Opioids Drug Average Price by Manufacturer (2021-2026)
3.4 Opioids Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Opioids Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Opioids Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Opioids Drug in 2025
3.6 Opioids Drug Market: Overall Company Footprint Analysis
3.6.1 Opioids Drug Market: Region Footprint
3.6.2 Opioids Drug Market: Company Product Type Footprint
3.6.3 Opioids Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Opioids Drug Production Value Comparison
4.1.1 United States VS China: Opioids Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Opioids Drug Production Comparison
4.2.1 United States VS China: Opioids Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Opioids Drug Consumption Comparison
4.3.1 United States VS China: Opioids Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Opioids Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Opioids Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Opioids Drug Production (2021-2026)
4.5 China Based Opioids Drug Manufacturers and Market Share
4.5.1 China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Opioids Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Opioids Drug Production (2021-2026)
4.6 Rest of World Based Opioids Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Opioids Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Opioids Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Opioids Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Oxycodone
5.2.2 Hydromorphone
5.2.3 Codeine
5.2.4 Fentanyl
5.3 Market Segment by Type
5.3.1 World Opioids Drug Production by Type (2021-2032)
5.3.2 World Opioids Drug Production Value by Type (2021-2032)
5.3.3 World Opioids Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL USE
6.1 World Opioids Drug Market Size Overview by Clinical Use: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Use
6.2.1 Cancer Pain
6.2.2 Postoperative Pain
6.2.3 Chronic Severe Pain
6.2.4 Other
6.3 Market Segment by Clinical Use
6.3.1 World Opioids Drug Production by Clinical Use (2021-2032)
6.3.2 World Opioids Drug Production Value by Clinical Use (2021-2032)
6.3.3 World Opioids Drug Average Price by Clinical Use (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Opioids Drug Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Immediate-release Tablet
7.2.2 Controlled-release Tablet
7.2.3 Injection
7.2.4 Transdermal Patch
7.2.5 Other
7.3 Market Segment by Dosage Form
7.3.1 World Opioids Drug Production by Dosage Form (2021-2032)
7.3.2 World Opioids Drug Production Value by Dosage Form (2021-2032)
7.3.3 World Opioids Drug Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Opioids Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pain Relief
8.2.2 Anesthesia
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Opioids Drug Production by Application (2021-2032)
8.3.2 World Opioids Drug Production Value by Application (2021-2032)
8.3.3 World Opioids Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Mallinckrodt Pharmaceuticals
9.1.1 Mallinckrodt Pharmaceuticals Details
9.1.2 Mallinckrodt Pharmaceuticals Major Business
9.1.3 Mallinckrodt Pharmaceuticals Opioids Drug Product and Services
9.1.4 Mallinckrodt Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
9.1.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Purdue Pharma
9.2.1 Purdue Pharma Details
9.2.2 Purdue Pharma Major Business
9.2.3 Purdue Pharma Opioids Drug Product and Services
9.2.4 Purdue Pharma Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Purdue Pharma Recent Developments/Updates
9.2.6 Purdue Pharma Competitive Strengths & Weaknesses
9.3 Johnson & Johnson Janssen
9.3.1 Johnson & Johnson Janssen Details
9.3.2 Johnson & Johnson Janssen Major Business
9.3.3 Johnson & Johnson Janssen Opioids Drug Product and Services
9.3.4 Johnson & Johnson Janssen Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Janssen Recent Developments/Updates
9.3.6 Johnson & Johnson Janssen Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical
9.4.1 Teva Pharmaceutical Details
9.4.2 Teva Pharmaceutical Major Business
9.4.3 Teva Pharmaceutical Opioids Drug Product and Services
9.4.4 Teva Pharmaceutical Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Recent Developments/Updates
9.4.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
9.5 Hikma Pharmaceuticals
9.5.1 Hikma Pharmaceuticals Details
9.5.2 Hikma Pharmaceuticals Major Business
9.5.3 Hikma Pharmaceuticals Opioids Drug Product and Services
9.5.4 Hikma Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Pharmaceuticals Recent Developments/Updates
9.5.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Pfizer
9.6.1 Pfizer Details
9.6.2 Pfizer Major Business
9.6.3 Pfizer Opioids Drug Product and Services
9.6.4 Pfizer Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Pfizer Recent Developments/Updates
9.6.6 Pfizer Competitive Strengths & Weaknesses
9.7 Indivior
9.7.1 Indivior Details
9.7.2 Indivior Major Business
9.7.3 Indivior Opioids Drug Product and Services
9.7.4 Indivior Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Indivior Recent Developments/Updates
9.7.6 Indivior Competitive Strengths & Weaknesses
9.8 Mundipharma
9.8.1 Mundipharma Details
9.8.2 Mundipharma Major Business
9.8.3 Mundipharma Opioids Drug Product and Services
9.8.4 Mundipharma Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Mundipharma Recent Developments/Updates
9.8.6 Mundipharma Competitive Strengths & Weaknesses
9.9 Yichang Humanwell
9.9.1 Yichang Humanwell Details
9.9.2 Yichang Humanwell Major Business
9.9.3 Yichang Humanwell Opioids Drug Product and Services
9.9.4 Yichang Humanwell Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Yichang Humanwell Recent Developments/Updates
9.9.6 Yichang Humanwell Competitive Strengths & Weaknesses
9.10 Northeast Pharmaceutical
9.10.1 Northeast Pharmaceutical Details
9.10.2 Northeast Pharmaceutical Major Business
9.10.3 Northeast Pharmaceutical Opioids Drug Product and Services
9.10.4 Northeast Pharmaceutical Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Northeast Pharmaceutical Recent Developments/Updates
9.10.6 Northeast Pharmaceutical Competitive Strengths & Weaknesses
9.11 Viatris
9.11.1 Viatris Details
9.11.2 Viatris Major Business
9.11.3 Viatris Opioids Drug Product and Services
9.11.4 Viatris Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Viatris Recent Developments/Updates
9.11.6 Viatris Competitive Strengths & Weaknesses
9.12 Depomed
9.12.1 Depomed Details
9.12.2 Depomed Major Business
9.12.3 Depomed Opioids Drug Product and Services
9.12.4 Depomed Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Depomed Recent Developments/Updates
9.12.6 Depomed Competitive Strengths & Weaknesses
9.13 Endo Pharmaceuticals
9.13.1 Endo Pharmaceuticals Details
9.13.2 Endo Pharmaceuticals Major Business
9.13.3 Endo Pharmaceuticals Opioids Drug Product and Services
9.13.4 Endo Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Endo Pharmaceuticals Recent Developments/Updates
9.13.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Opioids Drug Industry Chain
10.2 Opioids Drug Upstream Analysis
10.2.1 Opioids Drug Core Raw Materials
10.2.2 Main Manufacturers of Opioids Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Opioids Drug Production Mode
10.6 Opioids Drug Procurement Model
10.7 Opioids Drug Industry Sales Model and Sales Channels
10.7.1 Opioids Drug Sales Model
10.7.2 Opioids Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Opioids Drug Introduction
1.2 World Opioids Drug Supply & Forecast
1.2.1 World Opioids Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Opioids Drug Production (2021-2032)
1.2.3 World Opioids Drug Pricing Trends (2021-2032)
1.3 World Opioids Drug Production by Region (Based on Production Site)
1.3.1 World Opioids Drug Production Value by Region (2021-2032)
1.3.2 World Opioids Drug Production by Region (2021-2032)
1.3.3 World Opioids Drug Average Price by Region (2021-2032)
1.3.4 North America Opioids Drug Production (2021-2032)
1.3.5 Europe Opioids Drug Production (2021-2032)
1.3.6 Israel Opioids Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Opioids Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Opioids Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Opioids Drug Demand (2021-2032)
2.2 World Opioids Drug Consumption by Region
2.2.1 World Opioids Drug Consumption by Region (2021-2026)
2.2.2 World Opioids Drug Consumption Forecast by Region (2027-2032)
2.3 United States Opioids Drug Consumption (2021-2032)
2.4 China Opioids Drug Consumption (2021-2032)
2.5 Europe Opioids Drug Consumption (2021-2032)
2.6 Japan Opioids Drug Consumption (2021-2032)
2.7 South Korea Opioids Drug Consumption (2021-2032)
2.8 ASEAN Opioids Drug Consumption (2021-2032)
2.9 India Opioids Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Opioids Drug Production Value by Manufacturer (2021-2026)
3.2 World Opioids Drug Production by Manufacturer (2021-2026)
3.3 World Opioids Drug Average Price by Manufacturer (2021-2026)
3.4 Opioids Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Opioids Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Opioids Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Opioids Drug in 2025
3.6 Opioids Drug Market: Overall Company Footprint Analysis
3.6.1 Opioids Drug Market: Region Footprint
3.6.2 Opioids Drug Market: Company Product Type Footprint
3.6.3 Opioids Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Opioids Drug Production Value Comparison
4.1.1 United States VS China: Opioids Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Opioids Drug Production Comparison
4.2.1 United States VS China: Opioids Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Opioids Drug Consumption Comparison
4.3.1 United States VS China: Opioids Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Opioids Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Opioids Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Opioids Drug Production (2021-2026)
4.5 China Based Opioids Drug Manufacturers and Market Share
4.5.1 China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Opioids Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Opioids Drug Production (2021-2026)
4.6 Rest of World Based Opioids Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Opioids Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Opioids Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Opioids Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Oxycodone
5.2.2 Hydromorphone
5.2.3 Codeine
5.2.4 Fentanyl
5.3 Market Segment by Type
5.3.1 World Opioids Drug Production by Type (2021-2032)
5.3.2 World Opioids Drug Production Value by Type (2021-2032)
5.3.3 World Opioids Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL USE
6.1 World Opioids Drug Market Size Overview by Clinical Use: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Use
6.2.1 Cancer Pain
6.2.2 Postoperative Pain
6.2.3 Chronic Severe Pain
6.2.4 Other
6.3 Market Segment by Clinical Use
6.3.1 World Opioids Drug Production by Clinical Use (2021-2032)
6.3.2 World Opioids Drug Production Value by Clinical Use (2021-2032)
6.3.3 World Opioids Drug Average Price by Clinical Use (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Opioids Drug Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Immediate-release Tablet
7.2.2 Controlled-release Tablet
7.2.3 Injection
7.2.4 Transdermal Patch
7.2.5 Other
7.3 Market Segment by Dosage Form
7.3.1 World Opioids Drug Production by Dosage Form (2021-2032)
7.3.2 World Opioids Drug Production Value by Dosage Form (2021-2032)
7.3.3 World Opioids Drug Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Opioids Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pain Relief
8.2.2 Anesthesia
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Opioids Drug Production by Application (2021-2032)
8.3.2 World Opioids Drug Production Value by Application (2021-2032)
8.3.3 World Opioids Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Mallinckrodt Pharmaceuticals
9.1.1 Mallinckrodt Pharmaceuticals Details
9.1.2 Mallinckrodt Pharmaceuticals Major Business
9.1.3 Mallinckrodt Pharmaceuticals Opioids Drug Product and Services
9.1.4 Mallinckrodt Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
9.1.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Purdue Pharma
9.2.1 Purdue Pharma Details
9.2.2 Purdue Pharma Major Business
9.2.3 Purdue Pharma Opioids Drug Product and Services
9.2.4 Purdue Pharma Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Purdue Pharma Recent Developments/Updates
9.2.6 Purdue Pharma Competitive Strengths & Weaknesses
9.3 Johnson & Johnson Janssen
9.3.1 Johnson & Johnson Janssen Details
9.3.2 Johnson & Johnson Janssen Major Business
9.3.3 Johnson & Johnson Janssen Opioids Drug Product and Services
9.3.4 Johnson & Johnson Janssen Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Janssen Recent Developments/Updates
9.3.6 Johnson & Johnson Janssen Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical
9.4.1 Teva Pharmaceutical Details
9.4.2 Teva Pharmaceutical Major Business
9.4.3 Teva Pharmaceutical Opioids Drug Product and Services
9.4.4 Teva Pharmaceutical Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Recent Developments/Updates
9.4.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
9.5 Hikma Pharmaceuticals
9.5.1 Hikma Pharmaceuticals Details
9.5.2 Hikma Pharmaceuticals Major Business
9.5.3 Hikma Pharmaceuticals Opioids Drug Product and Services
9.5.4 Hikma Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Pharmaceuticals Recent Developments/Updates
9.5.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Pfizer
9.6.1 Pfizer Details
9.6.2 Pfizer Major Business
9.6.3 Pfizer Opioids Drug Product and Services
9.6.4 Pfizer Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Pfizer Recent Developments/Updates
9.6.6 Pfizer Competitive Strengths & Weaknesses
9.7 Indivior
9.7.1 Indivior Details
9.7.2 Indivior Major Business
9.7.3 Indivior Opioids Drug Product and Services
9.7.4 Indivior Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Indivior Recent Developments/Updates
9.7.6 Indivior Competitive Strengths & Weaknesses
9.8 Mundipharma
9.8.1 Mundipharma Details
9.8.2 Mundipharma Major Business
9.8.3 Mundipharma Opioids Drug Product and Services
9.8.4 Mundipharma Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Mundipharma Recent Developments/Updates
9.8.6 Mundipharma Competitive Strengths & Weaknesses
9.9 Yichang Humanwell
9.9.1 Yichang Humanwell Details
9.9.2 Yichang Humanwell Major Business
9.9.3 Yichang Humanwell Opioids Drug Product and Services
9.9.4 Yichang Humanwell Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Yichang Humanwell Recent Developments/Updates
9.9.6 Yichang Humanwell Competitive Strengths & Weaknesses
9.10 Northeast Pharmaceutical
9.10.1 Northeast Pharmaceutical Details
9.10.2 Northeast Pharmaceutical Major Business
9.10.3 Northeast Pharmaceutical Opioids Drug Product and Services
9.10.4 Northeast Pharmaceutical Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Northeast Pharmaceutical Recent Developments/Updates
9.10.6 Northeast Pharmaceutical Competitive Strengths & Weaknesses
9.11 Viatris
9.11.1 Viatris Details
9.11.2 Viatris Major Business
9.11.3 Viatris Opioids Drug Product and Services
9.11.4 Viatris Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Viatris Recent Developments/Updates
9.11.6 Viatris Competitive Strengths & Weaknesses
9.12 Depomed
9.12.1 Depomed Details
9.12.2 Depomed Major Business
9.12.3 Depomed Opioids Drug Product and Services
9.12.4 Depomed Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Depomed Recent Developments/Updates
9.12.6 Depomed Competitive Strengths & Weaknesses
9.13 Endo Pharmaceuticals
9.13.1 Endo Pharmaceuticals Details
9.13.2 Endo Pharmaceuticals Major Business
9.13.3 Endo Pharmaceuticals Opioids Drug Product and Services
9.13.4 Endo Pharmaceuticals Opioids Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Endo Pharmaceuticals Recent Developments/Updates
9.13.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Opioids Drug Industry Chain
10.2 Opioids Drug Upstream Analysis
10.2.1 Opioids Drug Core Raw Materials
10.2.2 Main Manufacturers of Opioids Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Opioids Drug Production Mode
10.6 Opioids Drug Procurement Model
10.7 Opioids Drug Industry Sales Model and Sales Channels
10.7.1 Opioids Drug Sales Model
10.7.2 Opioids Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Opioids Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioids Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioids Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioids Drug Production Value Market Share by Region (2021-2026)
Table 5. World Opioids Drug Production Value Market Share by Region (2027-2032)
Table 6. World Opioids Drug Production by Region (2021-2026) & (M Units)
Table 7. World Opioids Drug Production by Region (2027-2032) & (M Units)
Table 8. World Opioids Drug Production Market Share by Region (2021-2026)
Table 9. World Opioids Drug Production Market Share by Region (2027-2032)
Table 10. World Opioids Drug Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Opioids Drug Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Opioids Drug Major Market Trends
Table 13. World Opioids Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Opioids Drug Consumption by Region (2021-2026) & (M Units)
Table 15. World Opioids Drug Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Opioids Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioids Drug Producers in 2025
Table 18. World Opioids Drug Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Opioids Drug Producers in 2025
Table 20. World Opioids Drug Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Opioids Drug Company Evaluation Quadrant
Table 22. World Opioids Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 24. Opioids Drug Market: Company Product Type Footprint
Table 25. Opioids Drug Market: Company Product Application Footprint
Table 26. Opioids Drug Competitive Factors
Table 27. Opioids Drug New Entrant and Capacity Expansion Plans
Table 28. Opioids Drug Mergers & Acquisitions Activity
Table 29. United States VS China Opioids Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioids Drug Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Opioids Drug Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioids Drug Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 37. China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 47. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioids Drug Production by Type (2021-2026) & (M Units)
Table 49. World Opioids Drug Production by Type (2027-2032) & (M Units)
Table 50. World Opioids Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioids Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioids Drug Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Opioids Drug Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Opioids Drug Production Value by Clinical Use, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioids Drug Production by Clinical Use (2021-2026) & (M Units)
Table 56. World Opioids Drug Production by Clinical Use (2027-2032) & (M Units)
Table 57. World Opioids Drug Production Value by Clinical Use (2021-2026) & (USD Million)
Table 58. World Opioids Drug Production Value by Clinical Use (2027-2032) & (USD Million)
Table 59. World Opioids Drug Average Price by Clinical Use (2021-2026) & (USD/Unit)
Table 60. World Opioids Drug Average Price by Clinical Use (2027-2032) & (USD/Unit)
Table 61. World Opioids Drug Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Opioids Drug Production by Dosage Form (2021-2026) & (M Units)
Table 63. World Opioids Drug Production by Dosage Form (2027-2032) & (M Units)
Table 64. World Opioids Drug Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Opioids Drug Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Opioids Drug Average Price by Dosage Form (2021-2026) & (USD/Unit)
Table 67. World Opioids Drug Average Price by Dosage Form (2027-2032) & (USD/Unit)
Table 68. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Opioids Drug Production by Application (2021-2026) & (M Units)
Table 70. World Opioids Drug Production by Application (2027-2032) & (M Units)
Table 71. World Opioids Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Opioids Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Opioids Drug Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Opioids Drug Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Mallinckrodt Pharmaceuticals Major Business
Table 77. Mallinckrodt Pharmaceuticals Opioids Drug Product and Services
Table 78. Mallinckrodt Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 80. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Purdue Pharma Major Business
Table 83. Purdue Pharma Opioids Drug Product and Services
Table 84. Purdue Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Purdue Pharma Recent Developments/Updates
Table 86. Purdue Pharma Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Janssen Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Janssen Major Business
Table 89. Johnson & Johnson Janssen Opioids Drug Product and Services
Table 90. Johnson & Johnson Janssen Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Janssen Recent Developments/Updates
Table 92. Johnson & Johnson Janssen Competitive Strengths & Weaknesses
Table 93. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Teva Pharmaceutical Major Business
Table 95. Teva Pharmaceutical Opioids Drug Product and Services
Table 96. Teva Pharmaceutical Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Teva Pharmaceutical Recent Developments/Updates
Table 98. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 99. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 100. Hikma Pharmaceuticals Major Business
Table 101. Hikma Pharmaceuticals Opioids Drug Product and Services
Table 102. Hikma Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hikma Pharmaceuticals Recent Developments/Updates
Table 104. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 105. Pfizer Basic Information, Manufacturing Base and Competitors
Table 106. Pfizer Major Business
Table 107. Pfizer Opioids Drug Product and Services
Table 108. Pfizer Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Pfizer Recent Developments/Updates
Table 110. Pfizer Competitive Strengths & Weaknesses
Table 111. Indivior Basic Information, Manufacturing Base and Competitors
Table 112. Indivior Major Business
Table 113. Indivior Opioids Drug Product and Services
Table 114. Indivior Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Indivior Recent Developments/Updates
Table 116. Indivior Competitive Strengths & Weaknesses
Table 117. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 118. Mundipharma Major Business
Table 119. Mundipharma Opioids Drug Product and Services
Table 120. Mundipharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Mundipharma Recent Developments/Updates
Table 122. Mundipharma Competitive Strengths & Weaknesses
Table 123. Yichang Humanwell Basic Information, Manufacturing Base and Competitors
Table 124. Yichang Humanwell Major Business
Table 125. Yichang Humanwell Opioids Drug Product and Services
Table 126. Yichang Humanwell Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Yichang Humanwell Recent Developments/Updates
Table 128. Yichang Humanwell Competitive Strengths & Weaknesses
Table 129. Northeast Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Northeast Pharmaceutical Major Business
Table 131. Northeast Pharmaceutical Opioids Drug Product and Services
Table 132. Northeast Pharmaceutical Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Northeast Pharmaceutical Recent Developments/Updates
Table 134. Northeast Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Viatris Basic Information, Manufacturing Base and Competitors
Table 136. Viatris Major Business
Table 137. Viatris Opioids Drug Product and Services
Table 138. Viatris Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Viatris Recent Developments/Updates
Table 140. Viatris Competitive Strengths & Weaknesses
Table 141. Depomed Basic Information, Manufacturing Base and Competitors
Table 142. Depomed Major Business
Table 143. Depomed Opioids Drug Product and Services
Table 144. Depomed Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Depomed Recent Developments/Updates
Table 146. Depomed Competitive Strengths & Weaknesses
Table 147. Endo?Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Endo?Pharmaceuticals Major Business
Table 149. Endo?Pharmaceuticals Opioids Drug Product and Services
Table 150. Endo?Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Endo?Pharmaceuticals Recent Developments/Updates
Table 152. Endo?Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Global Key Players of Opioids Drug Upstream (Raw Materials)
Table 154. Global Opioids Drug Typical Customers
Table 155. Opioids Drug Typical Distributors
Table 1. World Opioids Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioids Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioids Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioids Drug Production Value Market Share by Region (2021-2026)
Table 5. World Opioids Drug Production Value Market Share by Region (2027-2032)
Table 6. World Opioids Drug Production by Region (2021-2026) & (M Units)
Table 7. World Opioids Drug Production by Region (2027-2032) & (M Units)
Table 8. World Opioids Drug Production Market Share by Region (2021-2026)
Table 9. World Opioids Drug Production Market Share by Region (2027-2032)
Table 10. World Opioids Drug Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Opioids Drug Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Opioids Drug Major Market Trends
Table 13. World Opioids Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Opioids Drug Consumption by Region (2021-2026) & (M Units)
Table 15. World Opioids Drug Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Opioids Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioids Drug Producers in 2025
Table 18. World Opioids Drug Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Opioids Drug Producers in 2025
Table 20. World Opioids Drug Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Opioids Drug Company Evaluation Quadrant
Table 22. World Opioids Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 24. Opioids Drug Market: Company Product Type Footprint
Table 25. Opioids Drug Market: Company Product Application Footprint
Table 26. Opioids Drug Competitive Factors
Table 27. Opioids Drug New Entrant and Capacity Expansion Plans
Table 28. Opioids Drug Mergers & Acquisitions Activity
Table 29. United States VS China Opioids Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioids Drug Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Opioids Drug Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioids Drug Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 37. China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 47. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioids Drug Production by Type (2021-2026) & (M Units)
Table 49. World Opioids Drug Production by Type (2027-2032) & (M Units)
Table 50. World Opioids Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioids Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioids Drug Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Opioids Drug Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Opioids Drug Production Value by Clinical Use, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioids Drug Production by Clinical Use (2021-2026) & (M Units)
Table 56. World Opioids Drug Production by Clinical Use (2027-2032) & (M Units)
Table 57. World Opioids Drug Production Value by Clinical Use (2021-2026) & (USD Million)
Table 58. World Opioids Drug Production Value by Clinical Use (2027-2032) & (USD Million)
Table 59. World Opioids Drug Average Price by Clinical Use (2021-2026) & (USD/Unit)
Table 60. World Opioids Drug Average Price by Clinical Use (2027-2032) & (USD/Unit)
Table 61. World Opioids Drug Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Opioids Drug Production by Dosage Form (2021-2026) & (M Units)
Table 63. World Opioids Drug Production by Dosage Form (2027-2032) & (M Units)
Table 64. World Opioids Drug Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Opioids Drug Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Opioids Drug Average Price by Dosage Form (2021-2026) & (USD/Unit)
Table 67. World Opioids Drug Average Price by Dosage Form (2027-2032) & (USD/Unit)
Table 68. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Opioids Drug Production by Application (2021-2026) & (M Units)
Table 70. World Opioids Drug Production by Application (2027-2032) & (M Units)
Table 71. World Opioids Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Opioids Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Opioids Drug Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Opioids Drug Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Mallinckrodt Pharmaceuticals Major Business
Table 77. Mallinckrodt Pharmaceuticals Opioids Drug Product and Services
Table 78. Mallinckrodt Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 80. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Purdue Pharma Major Business
Table 83. Purdue Pharma Opioids Drug Product and Services
Table 84. Purdue Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Purdue Pharma Recent Developments/Updates
Table 86. Purdue Pharma Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Janssen Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Janssen Major Business
Table 89. Johnson & Johnson Janssen Opioids Drug Product and Services
Table 90. Johnson & Johnson Janssen Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Janssen Recent Developments/Updates
Table 92. Johnson & Johnson Janssen Competitive Strengths & Weaknesses
Table 93. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Teva Pharmaceutical Major Business
Table 95. Teva Pharmaceutical Opioids Drug Product and Services
Table 96. Teva Pharmaceutical Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Teva Pharmaceutical Recent Developments/Updates
Table 98. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 99. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 100. Hikma Pharmaceuticals Major Business
Table 101. Hikma Pharmaceuticals Opioids Drug Product and Services
Table 102. Hikma Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hikma Pharmaceuticals Recent Developments/Updates
Table 104. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 105. Pfizer Basic Information, Manufacturing Base and Competitors
Table 106. Pfizer Major Business
Table 107. Pfizer Opioids Drug Product and Services
Table 108. Pfizer Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Pfizer Recent Developments/Updates
Table 110. Pfizer Competitive Strengths & Weaknesses
Table 111. Indivior Basic Information, Manufacturing Base and Competitors
Table 112. Indivior Major Business
Table 113. Indivior Opioids Drug Product and Services
Table 114. Indivior Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Indivior Recent Developments/Updates
Table 116. Indivior Competitive Strengths & Weaknesses
Table 117. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 118. Mundipharma Major Business
Table 119. Mundipharma Opioids Drug Product and Services
Table 120. Mundipharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Mundipharma Recent Developments/Updates
Table 122. Mundipharma Competitive Strengths & Weaknesses
Table 123. Yichang Humanwell Basic Information, Manufacturing Base and Competitors
Table 124. Yichang Humanwell Major Business
Table 125. Yichang Humanwell Opioids Drug Product and Services
Table 126. Yichang Humanwell Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Yichang Humanwell Recent Developments/Updates
Table 128. Yichang Humanwell Competitive Strengths & Weaknesses
Table 129. Northeast Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Northeast Pharmaceutical Major Business
Table 131. Northeast Pharmaceutical Opioids Drug Product and Services
Table 132. Northeast Pharmaceutical Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Northeast Pharmaceutical Recent Developments/Updates
Table 134. Northeast Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Viatris Basic Information, Manufacturing Base and Competitors
Table 136. Viatris Major Business
Table 137. Viatris Opioids Drug Product and Services
Table 138. Viatris Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Viatris Recent Developments/Updates
Table 140. Viatris Competitive Strengths & Weaknesses
Table 141. Depomed Basic Information, Manufacturing Base and Competitors
Table 142. Depomed Major Business
Table 143. Depomed Opioids Drug Product and Services
Table 144. Depomed Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Depomed Recent Developments/Updates
Table 146. Depomed Competitive Strengths & Weaknesses
Table 147. Endo?Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Endo?Pharmaceuticals Major Business
Table 149. Endo?Pharmaceuticals Opioids Drug Product and Services
Table 150. Endo?Pharmaceuticals Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Endo?Pharmaceuticals Recent Developments/Updates
Table 152. Endo?Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Global Key Players of Opioids Drug Upstream (Raw Materials)
Table 154. Global Opioids Drug Typical Customers
Table 155. Opioids Drug Typical Distributors
LIST OF FIGURES
Figure 1. Opioids Drug Picture
Figure 2. World Opioids Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioids Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioids Drug Production (2021-2032) & (M Units)
Figure 5. World Opioids Drug Average Price (2021-2032) & (USD/Unit)
Figure 6. World Opioids Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Opioids Drug Production Market Share by Region (2021-2032)
Figure 8. North America Opioids Drug Production (2021-2032) & (M Units)
Figure 9. Europe Opioids Drug Production (2021-2032) & (M Units)
Figure 10. Israel Opioids Drug Production (2021-2032) & (M Units)
Figure 11. Opioids Drug Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Opioids Drug Consumption (2021-2032) & (M Units)
Figure 14. World Opioids Drug Consumption Market Share by Region (2021-2032)
Figure 15. United States Opioids Drug Consumption (2021-2032) & (M Units)
Figure 16. China Opioids Drug Consumption (2021-2032) & (M Units)
Figure 17. Europe Opioids Drug Consumption (2021-2032) & (M Units)
Figure 18. Japan Opioids Drug Consumption (2021-2032) & (M Units)
Figure 19. South Korea Opioids Drug Consumption (2021-2032) & (M Units)
Figure 20. ASEAN Opioids Drug Consumption (2021-2032) & (M Units)
Figure 21. India Opioids Drug Consumption (2021-2032) & (M Units)
Figure 22. Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Opioids Drug Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Opioids Drug Markets in 2025
Figure 25. United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Opioids Drug Production Market Share 2025
Figure 29. China Based Manufacturers Opioids Drug Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Opioids Drug Production Market Share 2025
Figure 31. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Opioids Drug Production Value Market Share by Type in 2025
Figure 33. Oxycodone
Figure 34. Hydromorphone
Figure 35. Codeine
Figure 36. Fentanyl
Figure 37. World Opioids Drug Production Market Share by Type (2021-2032)
Figure 38. World Opioids Drug Production Value Market Share by Type (2021-2032)
Figure 39. World Opioids Drug Average Price by Type (2021-2032) & (USD/Unit)
Figure 40. World Opioids Drug Production Value by Clinical Use, (USD Million), 2021 & 2025 & 2032
Figure 41. World Opioids Drug Production Value Market Share by Clinical Use in 2025
Figure 42. Cancer Pain
Figure 43. Postoperative Pain
Figure 44. Chronic Severe Pain
Figure 45. Other
Figure 46. World Opioids Drug Production Market Share by Clinical Use (2021-2032)
Figure 47. World Opioids Drug Production Value Market Share by Clinical Use (2021-2032)
Figure 48. World Opioids Drug Average Price by Clinical Use (2021-2032) & (USD/Unit)
Figure 49. World Opioids Drug Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 50. World Opioids Drug Production Value Market Share by Dosage Form in 2025
Figure 51. Immediate-releaseTablet
Figure 52. Controlled-releaseTablet
Figure 53. Injection
Figure 54. Transdermal Patch
Figure 55. Other
Figure 56. World Opioids Drug Production Market Share by Dosage Form (2021-2032)
Figure 57. World Opioids Drug Production Value Market Share by Dosage Form (2021-2032)
Figure 58. World Opioids Drug Average Price by Dosage Form (2021-2032) & (USD/Unit)
Figure 59. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Opioids Drug Production Value Market Share by Application in 2025
Figure 61. Pain Relief
Figure 62. Anesthesia
Figure 63. Others
Figure 64. World Opioids Drug Production Market Share by Application (2021-2032)
Figure 65. World Opioids Drug Production Value Market Share by Application (2021-2032)
Figure 66. World Opioids Drug Average Price by Application (2021-2032) & (USD/Unit)
Figure 67. Opioids Drug Industry Chain
Figure 68. Opioids Drug Procurement Model
Figure 69. Opioids Drug Sales Model
Figure 70. Opioids Drug Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Opioids Drug Picture
Figure 2. World Opioids Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioids Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioids Drug Production (2021-2032) & (M Units)
Figure 5. World Opioids Drug Average Price (2021-2032) & (USD/Unit)
Figure 6. World Opioids Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Opioids Drug Production Market Share by Region (2021-2032)
Figure 8. North America Opioids Drug Production (2021-2032) & (M Units)
Figure 9. Europe Opioids Drug Production (2021-2032) & (M Units)
Figure 10. Israel Opioids Drug Production (2021-2032) & (M Units)
Figure 11. Opioids Drug Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Opioids Drug Consumption (2021-2032) & (M Units)
Figure 14. World Opioids Drug Consumption Market Share by Region (2021-2032)
Figure 15. United States Opioids Drug Consumption (2021-2032) & (M Units)
Figure 16. China Opioids Drug Consumption (2021-2032) & (M Units)
Figure 17. Europe Opioids Drug Consumption (2021-2032) & (M Units)
Figure 18. Japan Opioids Drug Consumption (2021-2032) & (M Units)
Figure 19. South Korea Opioids Drug Consumption (2021-2032) & (M Units)
Figure 20. ASEAN Opioids Drug Consumption (2021-2032) & (M Units)
Figure 21. India Opioids Drug Consumption (2021-2032) & (M Units)
Figure 22. Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Opioids Drug Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Opioids Drug Markets in 2025
Figure 25. United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Opioids Drug Production Market Share 2025
Figure 29. China Based Manufacturers Opioids Drug Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Opioids Drug Production Market Share 2025
Figure 31. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Opioids Drug Production Value Market Share by Type in 2025
Figure 33. Oxycodone
Figure 34. Hydromorphone
Figure 35. Codeine
Figure 36. Fentanyl
Figure 37. World Opioids Drug Production Market Share by Type (2021-2032)
Figure 38. World Opioids Drug Production Value Market Share by Type (2021-2032)
Figure 39. World Opioids Drug Average Price by Type (2021-2032) & (USD/Unit)
Figure 40. World Opioids Drug Production Value by Clinical Use, (USD Million), 2021 & 2025 & 2032
Figure 41. World Opioids Drug Production Value Market Share by Clinical Use in 2025
Figure 42. Cancer Pain
Figure 43. Postoperative Pain
Figure 44. Chronic Severe Pain
Figure 45. Other
Figure 46. World Opioids Drug Production Market Share by Clinical Use (2021-2032)
Figure 47. World Opioids Drug Production Value Market Share by Clinical Use (2021-2032)
Figure 48. World Opioids Drug Average Price by Clinical Use (2021-2032) & (USD/Unit)
Figure 49. World Opioids Drug Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 50. World Opioids Drug Production Value Market Share by Dosage Form in 2025
Figure 51. Immediate-releaseTablet
Figure 52. Controlled-releaseTablet
Figure 53. Injection
Figure 54. Transdermal Patch
Figure 55. Other
Figure 56. World Opioids Drug Production Market Share by Dosage Form (2021-2032)
Figure 57. World Opioids Drug Production Value Market Share by Dosage Form (2021-2032)
Figure 58. World Opioids Drug Average Price by Dosage Form (2021-2032) & (USD/Unit)
Figure 59. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Opioids Drug Production Value Market Share by Application in 2025
Figure 61. Pain Relief
Figure 62. Anesthesia
Figure 63. Others
Figure 64. World Opioids Drug Production Market Share by Application (2021-2032)
Figure 65. World Opioids Drug Production Value Market Share by Application (2021-2032)
Figure 66. World Opioids Drug Average Price by Application (2021-2032) & (USD/Unit)
Figure 67. Opioids Drug Industry Chain
Figure 68. Opioids Drug Procurement Model
Figure 69. Opioids Drug Sales Model
Figure 70. Opioids Drug Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
